Clinical Trials: Thalassemia

Oakland : Children's Hospital Oakland

Safety, Efficacy and Pharmacokinetics of an Oral Iron Chelator Given for a Year to Pediatric Patients With Iron Overload

Boston : Children's Hospital Boston

Safety, Efficacy and Pharmacokinetics of an Oral Iron Chelator Given for a Year to Pediatric Patients With Iron Overload

Toronto : Toronto Sick Kids Hospital

Safety, Efficacy and Pharmacokinetics of an Oral Iron Chelator Given for a Year to Pediatric Patients With Iron Overload

Créteil : Groupe Hospitalier Henri Mondor

Study to Determine the Safety and Tolerability of Sotatercept (ACE-011) in Adults With Beta( β)- Thalassemia.

Paris : Hôpital Necker-Enfants Malades

Study to Determine the Safety and Tolerability of Sotatercept (ACE-011) in Adults With Beta( β)- Thalassemia.

Athens : Novartis Investigative Site

Safety and Efficacy of Deferasirox in β-thalassaemia Patients With Severe Cardiac Iron Overload

Patra : Novartis Investigative Site

Safety and Efficacy of Deferasirox in β-thalassaemia Patients With Severe Cardiac Iron Overload

Thessaloniki : George Papanicolaou Hospital

Evaluating the Safety and Effectiveness of Mozobil Mobilization in Adults With Beta-Thalassemia Major

Cagliari : Novartis Investigative Site

Phase I Study to Examine the Effect of Deferasirox on Renal Hemodynamics in β-thalassemia Patients With Transfusional Iron Overload

Cagliari : Ospedale Regionale Mecrocitemie

Safety, Efficacy and Pharmacokinetics of an Oral Iron Chelator Given for a Year to Pediatric Patients With Iron Overload

Genoa : Centro della Microcitemia e delle Anemie Congenite

Safety, Efficacy and Pharmacokinetics of an Oral Iron Chelator Given for a Year to Pediatric Patients With Iron Overload

Genova : Novartis Investigative Site

Phase I Study to Examine the Effect of Deferasirox on Renal Hemodynamics in β-thalassemia Patients With Transfusional Iron Overload

Milano : Novartis Investigative Site

Phase I Study to Examine the Effect of Deferasirox on Renal Hemodynamics in β-thalassemia Patients With Transfusional Iron Overload

View More »

Orbassano : Novartis Investigative Site

Phase I Study to Examine the Effect of Deferasirox on Renal Hemodynamics in β-thalassemia Patients With Transfusional Iron Overload

Orbassano : Thalassemia Center San Luigi Hospital

Safety, Efficacy and Pharmacokinetics of an Oral Iron Chelator Given for a Year to Pediatric Patients With Iron Overload

Sassari : Novartis Investigative Site

Phase I Study to Examine the Effect of Deferasirox on Renal Hemodynamics in β-thalassemia Patients With Transfusional Iron Overload

London : UCL Cancer Institue

Study to Determine the Safety and Tolerability of Sotatercept (ACE-011) in Adults With Beta( β)- Thalassemia.